Canada signs deal to buy 20,000 doses more of GSK COVID-19 drug
Canada signs deal to buy 20,000 doses more of GSK COVID-19 drug
GlaxoSmithKline PLC said on Thursday it has signed agreements with the Canadian government to supply 20,000 doses more of the COVID-19 drug sotrovimab. Read More